HighTower Advisors
GILD icon

HighTower Advisors’s Gilead Sciences GILD Stock Holding History

HighTower Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,100
Closed -$4.49K – 3834
2024
Q2 		$4.49K Buy
5,100
+5,000
+5,000% +$334K ﹤0.01% 3491
2024
Q1 		$1.17K Buy
+100
New +$7.69K ﹤0.01% 3512
2023
Q2 		– Sell
-100
Closed -$1.67K – 3530
2023
Q1 		$1.67K Buy
+100
New +$8.28K ﹤0.01% 3299
2022
Q3 		– Sell
-100
Closed -$1K – 3238
2022
Q2 		$1K Buy
+100
New +$6.19K ﹤0.01% 3182
2021
Q3 		– Sell
-100
Closed -$1K – 3280
2021
Q2 		$1K Buy
+100
New +$6.68K ﹤0.01% 3104
2021
Q1 		– Sell
-164
Closed -$53K – 3133
2020
Q4 		$53K Sell
164
-17,836
-99% -$1.08M ﹤0.01% 2405
2020
Q3 		$13K Buy
+18,000
New +$1.25M ﹤0.01% 2401
2020
Q2 		– Sell
-1,000
Closed -$8K – 2469
2020
Q1 		$8K Buy
+1,000
New +$69.1K ﹤0.01% 2129
2019
Q3 		– Sell
-2,000
Closed -$3K – 2460
2019
Q2 		$3K Buy
+2,000
New +$132K ﹤0.01% 2340
2019
Q1 		– Sell
-16,000
Closed -$46K – 2345
2018
Q4 		$46K Hold
16,000
– – ﹤0.01% 2037
2018
Q3 		$46K Buy
+16,000
New +$1.21M ﹤0.01% 2132
2018
Q2 		– Sell
-2,000
Closed -$1K – 2301
2018
Q1 		$1K Sell
2,000
-6,500
-76% -$517K ﹤0.01% 2167
2017
Q4 		$2K Sell
8,500
-6,700
-44% -$509K ﹤0.01% 2235
2017
Q3 		$72K Sell
15,200
-1,300
-8% -$99.4K ﹤0.01% 2056
2017
Q2 		$56K Buy
+16,500
New +$1.1M ﹤0.01% 2023
2017
Q1 		– Sell
-5,600
Closed -$2K – 2117
2016
Q4 		$2K Buy
+5,600
New +$416K ﹤0.01% 1908
2014
Q3 		– Sell
-10,000
Closed -$7K – 1590
2014
Q2 		$7K Sell
10,000
-800
-7% -$62.3K ﹤0.01% 1590
2014
Q1 		$11K Buy
+10,800
New +$847K ﹤0.01% 1522

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HighTower Advisors's GILD Position: Q1 2026 in Review

HighTower Advisors reduced its Gilead Sciences (GILD) stake by 13% in Q1 2026, selling an estimated $29.6M and leaving 1,450,177 shares worth $202M. The position accounts for 0.21% of the portfolio, ranked #96.

HighTower Advisors first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $204M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • HighTower Advisors held 1,450,177 shares of Gilead Sciences worth $202M as of Q1 2026.
  • HighTower Advisors sold 211,178 Gilead Sciences shares in Q1 2026, an estimated $29.6M.
  • Gilead Sciences made up 0.21% of HighTower Advisors's portfolio in Q1 2026, its #96 holding.
  • HighTower Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's Gilead Sciences position peaked at $204M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.